Paul Yun, MD
Otolaryngology · Menlo Park, CANPI 1174583355
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,793 of the $41,026 with a category attached, or 99.4%. Intersect ENT, Inc. accounts for 78.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $18,019 and has fallen 76.7% since, to $4,200 in 2023. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $719.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$32K
- Medtronic$9K
- Aerin Medical Inc.$48
- Stryker$35
- Smith+Nephew$31
- Optinose US, Inc.$21
What the payments were for
- Consulting fees$40,79399%
- Food & beverage$2331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 41 | $32,123 |
| Medtronic | 11 | $8,768 |
| Aerin Medical Inc. | 1 | $48 |
| Stryker | 2 | $35 |
| Smith+Nephew | 1 | $31 |
| Optinose US, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,026 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 24 | $2,596 |
| Ipratropium Bromide | 56 | $2,029 |
| Azelastine Hcl | 38 | $1,230 |
| Omeprazole | 18 | $362 |
| Pantoprazole Sodium | 16 | $314 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $220 |
| Mometasone Furoate | 27 | $217 |
| Mupirocin | 20 | $174 |
| Methylprednisolone | 13 | $123 |
| Prednisone | 16 | $98 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Menlo Park
- Brian WeeksSan Diego$924K
- Randall OwRoseville$613K
- Amir MoradiVista$389K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
- Todd MillerNewport Beach$259K
- Jeffrey SuhLos Angeles$223K
- Dennis TangLos Angeles$209K
- Jeffrey FeinfieldThousand Oaks$160K
- Jonathan SykesGranite Bay$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.